Parabilis Medicines, Inc. (PBLS) Stock Ticker
PBLS right now
Market factors today
Unlock the full PBLS picture
About Parabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
PBLS stock facts
| Ticker symbol | PBLS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $3.6B |
| CEO | Mathai Mammen |
| Employees | 145 |
| Headquarters | Cambridge, MA, US |
| IPO date | 2026-06-10 |
| Website | www.parabilismed.com |
What you can see for PBLS on Tickr
Live PBLS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the PBLS report.
Rankings
FAQ
What is the ticker symbol for Parabilis Medicines, Inc.?
The ticker symbol for Parabilis Medicines, Inc. is PBLS, listed on the NASDAQ.
What is PBLS?
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.